RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

Erstveröffentlichung
2008Authors
Schmitt, Michael
Schmitt, Anita
Rojewski, Markus T.
Chen, Jinfei
Giannopoulos, Krzysztof
Wissenschaftlicher Artikel
Published in
Blood ; 111 (2008), 3. - S. 1357-1365. - ISSN 0006-4971
Link to publication
https://dx.doi.org/10.1182/blood-2007-07-099366Institutions
UKU. Klinik für Innere Medizin IIIInstitut für Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH (IKT)
Subject headings
[Free subject headings]: t-cell responses | tumor-associated antigens | chronic myelogenous leukemia | international working group | immune-responses | wt1 peptide | lymphocytes | cancer | transplantation | expression[DDC subject group]: DDC 610 / Medicine & health